LAUSR

Tothova, E., Keil, F., Autzinger, E.M., Thaler, J., Gisslinger, H., Lang, A., Egyed, M., Womastek, I. & Zojer, N. (2010) Light chaininduced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study. Journal of Clinical Oncology, 28, 4635– 4641. Morgan, G.J., Davies, F.E., Gregory, W.M., Bell, S.E., Szubert, A.J., Cook, G., Drayson, M.T., Owen, R.G., Ross, F.M., Jackson, G.H. & Child, J.A. (2013) Long-term follow-up of MRC Myeloma IX trial: survival outcomes with bisphosphonate and thalidomide treatment. Clinical Cancer Research, 19, 6030–6038. Palumbo, A., Cavallo, F., Gay, F., Di Raimondo, F., Ben Yehuda, D., Petrucci, M.T., Pezzatti, S., Caravita, T., Cerrato, C., Ribakovsky, E., Genuardi, M., Cafro, A., Marcatti, M., Catalano, L., Offidani, M., Carella, A.M., Zamagni, E., Patriarca, F., Musto, P., Evangelista, A., Ciccone, G., Omede, P., Crippa, C., Corradini, P., Nagler, A., Boccadoro, M. & Cavo, M. (2014) Autologous transplantation and maintenance therapy in multiple myeloma. New England Journal of Medicine, 371, 895–905.